Tuesday, June 16, 2026

North Korea Kim Jong-un Supreme Commander Appointment 14th Anniversary…”Revolutionary Force Strengthening Peak Period”

North Korea celebrates Kim Jong Un's military leadership, claiming unparalleled advancements in military strength and ideological fortitude.

First Korea–Russia Business Dialogue Under Lee Administration Signals Thaw

South Korea and Russia will hold a semi-official dialogue to discuss economic cooperation under President Lee's pragmatic diplomacy.

2024 Drone Controversy: How South Korea’s Military May Have Ignored Civilian UAV Deployments to North Korea

North Korea claims a South Korean drone infiltrated its airspace, raising suspicions of KDIC's involvement in drone deployments since 2024.

Tag: clinical trials

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

KDDF Chief Calls for Structural Shift in Korea Biotech Beyond Technology Transfer

Dr. Park Young-min urges South Korea's biotech sector to shift from tech transfer to global collaboration for sustainable growth.

Artiva to Advance NK Cell Therapy Into Phase 3 for Rheumatoid Arthritis After Positive Mid-Stage Data

GC Cell's Artiva Biotherapeutics advances NK cell therapy AlloNK to Phase 3 trials for rheumatoid arthritis after promising Phase 2 results.

Humedix Seeks Domestic Approval for PN-HA Composite Filler Valpien

Huons Group's Humedix is set to launch Valpien, a novel composite filler, improving wrinkle treatment with less pain and effective results.

Korea’s First Domestic CAR-T Therapy Just Won Approval—and That’s a Bigger Deal Than It Sounds

CureCell's CAR-T therapy Rimkato is the first approved in South Korea, enhancing access to treatment for blood cancer patients.

Qurient Mocaciclib’s CDK7 Inhibitor is Revolutionizing High-Risk Pediatric Brain Cancer Therapy

Qurient's Mocaciclib shows promising results for pediatric brain tumors, enhancing survival and overcoming treatment barriers.

Daewoong Pharmaceutical and Primind’s Strategic Investment in American Biotech General Proximity

Daewoong Pharmaceutical invests in biotech firms to enhance drug development using Induced Proximity technology and expand globally.

Why 20 Years of Stem Cell Therapy Research Still Lacks Proven Results

Stem cell therapy shows promise but faces hurdles in clinical applications and approvals, with few successful treatments available.

Samsung’s G-CROWN Platform is Revolutionizing Gene Therapy for Rare Diseases in Asia

Samsung Medical Center launches G-CROWN platform to develop gene therapies for rare diseases, aiming to reduce reliance on imports.

Solum Healthcare Announces AI-Based Urine Test for Cancer at AACR Annual Meeting 2026

Solum Healthcare presented AI-driven non-invasive cancer detection using urine samples at AACR 2026, attracting global interest and discussions.

Unlocking Cancer Treatment: Celltrion’s 4 Promising ADC Drugs Enter Patient Trials in 2026

Celltrion's ADC cancer drug candidates CT-P70, CT-P71, and CT-P73 enter patient dosing, targeting various cancers with Fast Track Designation.

Penetrium Bioscience Announces Finalization of New Clinical Strategy for Targeted Cancer Therapies

Penetrium Bioscience reveals new clinical strategy to combat drug resistance in cancer therapies at AACR 2026, launching Phase 2 trials.

SillaJen’s Breakthrough Cancer BAL0891 Drug Set for ASCO 2026 Reveal

SillaJen's anticancer drug BAL0891 will be presented at the ASCO Annual Meeting, currently in Phase 1 trials for solid tumors and AML.

Lunit’s AI-based bile duct cancer study selected for rapid oral presentation at U.S. oncology conference

Lunit will present five research abstracts at ASCO 2026, showcasing the expanding role of AI biomarkers in cancer treatment.

Alzheimer’s Breakthrough: Monthly Injections of IVL3003 vs. GB-5001A—Which is More Effective?

New long-acting injectable formulations of donepezil for Alzheimer's aim to improve adherence and efficacy, easing caregiver burdens.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.